Journal Article Ppublish
PubMed: 39530361 DOI: 10.1002/ajh.27525
Globalization in clinical drug development for sickle cell disease.
Am J Hematol 100(1):4-9
Authors: Enrico Costa, Russell E Ware, Léon Tshilolo, Julie Makani, Hubert G M Leufkens, Lucio Luzzatto
Affiliations
- World Health Organization Collaborating Centre for Pharmaceutical Policy and Regulation, Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht University, Utrecht, The Netherlands.
- Division of Hematology and Global Health Center, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
- Institut de Recherche Biomédicale 1-Health, CEFA-Monkole, Kinshasa, Congo.
- Department of Hematology and Blood Transfusion at Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania. Sickleinafrica, Dar-es-Salaam, Tanzania and Imperial College London, London, UK.
- Regulatory Science and Pharmaceutical Policy, Utrecht University, Utrecht, The Netherlands.
- Department of Hematology, University of Florence, Florence, Italy.
MeSH
Cells, Drug Development, Hematology, Anemia, Sickle Cell, Pharmaceutical Preparations
Cited by
- Globalization in clinical drug development for sickle cell disease. Am J Hematol, 2024